SABBYY 13G BLRX 5.26.20

Company

BioLineRx Ltd.

Filed

May 26, 2020

Accession Number

0001535610-20-000095

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →